Future studies should investigate the regulation of MAFB expression in response to environmental factors, such as NSAID use, and the effect of epigenetic modifications and their implications for variable clinical features in MCTO patients. The gene discussed is MAFB; the disease is multicentric carpo-tarsal osteolysis with or without nephropathy.